# Inulin Supplementation for Reducing Inflammation and Knee Pain in Older Adults With Osteoarthritis

> **NCT07189585** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Yale University** · enrollment: 84 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** inulin
- **DRUG:** Maltodextrin (Placebo)

## Key facts

- **NCT ID:** NCT07189585
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2025-09-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07189585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07189585, "Inulin Supplementation for Reducing Inflammation and Knee Pain in Older Adults With Osteoarthritis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07189585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*